Comparative trial of cefuroxime axetil in recurrent urinary tract infections illustrating importance of 6-week follow-up.

AUTOR(ES)

Brumfitt, W

RESUMO

Women with recurrent urinary tract infections treated with cefuroxime axetil (500 or 250 mg twice daily) for 7 days had a higher relapse rate when tested 6 weeks after the start of treatment than those given amoxycillin (250 mg three times daily). The poor performance of cefuroxime axetil is explained by variable bioavailability.

Documentos Relacionados

• Enoxacin relieves symptoms of recurrent urinary infections more rapidly than cefuroxime axetil.
• Trabeculectomy: long-term follow-up.
• Evaluation of aztreonam in difficult-to-treat infections with prolonged posttreatment follow-up.
• Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
• Factors affecting school health follow-up.